Skip to content

Clinical trials

Expanded access Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Phase: Expanded access Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20081

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
No longer available6
Approved for marketing2
Available2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Ariad Pharmaceuticals1
Christopher Dvorak1
Emory University1
OHSU Knight Cancer Institute1
Pusan National University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive10
Blast Crisis2
Graft vs Host Disease2
Leukemia2
Leukemia, Myeloid, Acute2
Myelodysplastic Syndromes2
Bone Diseases1
Bone Diseases, Developmental1
Bone Marrow Diseases1
Bone Marrow Failure Disorders1

Trials

Showing 51 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.